Global Recombinant Peptides Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 160406
- Pages: 150
-
Format:
Summary
The global Recombinant Peptides market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Glucagon
Calcitonin
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Recombinant Peptides of Research
1.1.1 Definition
1.1.2 Specifications of Recombinant Peptides
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Glucagon Overview
1.2.1.2 Calcitonin Overview
1.2.1.3 Others Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Oncology
1.3.1.2 Blood Disorders
1.3.1.3 Infectious Diseases
1.3.1.4 Autoimmune Diseases
1.3.1.5 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Glucagon Market Size 2018-2023
3.1.1.1 Global Glucagon Market Size and Growth Rate 2018-2023
3.1.1.2 Global Glucagon Market Size by Region 2018-2023
3.1.2 Calcitonin Market Size 2018-2023
3.1.2.1 Global Calcitonin Market Size and Growth Rate 2018-2023
3.1.2.2 Global Calcitonin Market Size by Region 2018-2023
3.1.3 Others Market Size 2018-2023
3.1.3.1 Global Others Market Size and Growth Rate 2018-2023
3.1.3.2 Global Others Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Glucagon Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Glucagon Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Glucagon Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Calcitonin Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Calcitonin Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Calcitonin Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 Others Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Oncology Market Size 2018-2023
4.1.1.1 Global Oncology Market Size and Growth Rate 2018-2023
4.1.1.2 Global Oncology Market Size by Region 2018-2023
4.1.2 Blood Disorders Market Size 2018-2023
4.1.2.1 Global Blood Disorders Market Size and Growth Rate 2018-2023
4.1.2.2 Global Blood Disorders Market Size by Region 2018-2023
4.1.3 Infectious Diseases Market Size 2018-2023
4.1.3.1 Global Infectious Diseases Market Size and Growth Rate 2018-2023
4.1.3.2 Global Infectious Diseases Market Size by Region 2018-2023
4.1.4 Autoimmune Diseases Market Size 2018-2023
4.1.4.1 Global Autoimmune Diseases Market Size and Growth Rate 2018-2023
4.1.4.2 Global Autoimmune Diseases Market Size by Region 2018-2023
4.1.5 Others Market Size 2018-2023
4.1.5.1 Global Others Market Size and Growth Rate 2018-2023
4.1.5.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Oncology Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Oncology Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Oncology Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Blood Disorders Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Blood Disorders Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Blood Disorders Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Infectious Diseases Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Infectious Diseases Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Infectious Diseases Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Autoimmune Diseases Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Autoimmune Diseases Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Autoimmune Diseases Market Estimates and Forecasts by Region 2024E-2030F
4.2.5 Others Market Estimates and Forecasts 2024E-2030F
4.2.5.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.5.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Recombinant Peptides Market Competition
7.1.1 Global Recombinant Peptides Market by Companies
7.1.2 Global Recombinant Peptides Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Sandoz Pharma
8.1.1 Sandoz Pharma Company Profile
8.1.2 Sandoz Pharma Product Portfolio
8.1.3 Sandoz Pharma Business Performance
8.1.4 Sandoz Pharma Development Overview
8.2 Stada Arzneimittel
8.2.1 Stada Arzneimittel Company Profile
8.2.2 Stada Arzneimittel Product Portfolio
8.2.3 Stada Arzneimittel Business Performance
8.2.4 Stada Arzneimittel Development Overview
8.3 Amgen
8.3.1 Amgen Company Profile
8.3.2 Amgen Product Portfolio
8.3.3 Amgen Business Performance
8.3.4 Amgen Development Overview
8.4 Hospira
8.4.1 Hospira Company Profile
8.4.2 Hospira Product Portfolio
8.4.3 Hospira Business Performance
8.4.4 Hospira Development Overview
8.5 Actavis
8.5.1 Actavis Company Profile
8.5.2 Actavis Product Portfolio
8.5.3 Actavis Business Performance
8.5.4 Actavis Development Overview
8.6 Cipla Ltd.
8.6.1 Cipla Ltd. Company Profile
8.6.2 Cipla Ltd. Product Portfolio
8.6.3 Cipla Ltd. Business Performance
8.6.4 Cipla Ltd. Development Overview
8.7 Wockhardt Ltd.
8.7.1 Wockhardt Ltd. Company Profile
8.7.2 Wockhardt Ltd. Product Portfolio
8.7.3 Wockhardt Ltd. Business Performance
8.7.4 Wockhardt Ltd. Development Overview
8.8 Biocon Ltd.
8.8.1 Biocon Ltd. Company Profile
8.8.2 Biocon Ltd. Product Portfolio
8.8.3 Biocon Ltd. Business Performance
8.8.4 Biocon Ltd. Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
